Angiographic and histological results following implantation of a novel stent-on-a-wire in the animal model

EuroIntervention

Volumn 8, Issue 3, 2012, Pages 390-399

  Diletti, Roberto ^a   Garcia Garcia, Hector M ^a   Van Geuns, Robert Jan ^a   Farooq, Vasim ^a   Bailey, Lynn ^b   Rousselle, Serge ^c   Kopia, Gregory ^d   Easterbrook, William ^e   Pomeranz, Mark ^e   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CBSET Inc   (United States)

^c Alizee Pathology   (United States)

^d Kopia Consulting   (United States)

^e Svelte Medical Systems   (United States)

Author keywords

Angiography; Histology; Stent On A wire

Indexed keywords

FIBRINOGEN;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON EXPANDABLE COBALT CHROMIUM STENT; BALLOON EXPANDABLE STENT; CARDIOVASCULAR RESPONSE; CELL INFILTRATION; CONTROLLED STUDY; CORONARY STENT; ENDOTHELIUM CELL; FIBRINOGEN BLOOD LEVEL; HISTOPATHOLOGY; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SPINDLE CELL; SWINE; TREATMENT FAILURE; TREATMENT RESPONSE;

ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY VESSELS; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; MYOCARDIUM; STENTS; SWINE;

EID: 84872092608     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I3A59     Document Type: Article

References (24)

1. O'Neill BJ, Feldman RL, Palmer SL, Creighton J, Fitzgerald N, Foster CJ, Teskey RJ, Kells CM, Corbett BN, Macdonald RG. Comparison of fixed-wire and over-the-wire balloon dilatation systems for percutaneous transluminal coronary angioplasty. Am J Cardiol. 1994;73:113-116.
2. Thomas ES, Williams DO, Neiderman AL, Douglas JS, King SB, 3rd. Efficacy of a new angioplasty catheter for severely narrowed coronary lesions. J Am Coll Cardiol. 1988;12:694-702.
3. Sarno G, Okamura T, Gomez-Lara J, Garg S, Girasis C, Kopia G, Pomeranz M, Easterbrook W, van Geuns RJ, van der Giessen W, Serruys PW. The coronary Stent-On-A-Wire (SOAW). EuroIntervention. 2010;6:413-417.
4. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007;297:1992-2000.
5. Ormiston JA, Mahmud E, Turco MA, Popma JJ, Weissman N, Cannon LA, Mann T, Lucca MJ, Lim ST, Hall JJ, McClean D, Dobies D, Mandinov L, Baim DS. Direct stenting with the taxus liberte drug-eluting stent: Results from the taxus atlas direct stent study. JACC Cardiovasc Interv. 2008;1:150-160.
6. Wilson SH, Berger PB, Mathew V, Bell MR, Garratt KN, Rihal CS, Bresnahan JF, Grill DE, Melby S, Holmes DR, Jr. Immediate and late outcomes after direct stent implantation without balloon predilation. J Am Coll Cardiol. 2000;35:937-943.
7. Briguori C, Sheiban I, De Gregorio J, Anzuini A, Montorfano M, Pagnotta P, Marsico F, Leonardo F, Di Mario C, Colombo A. Direct coronary stenting without predilation. J Am Coll Cardiol. 1999;34:1910-1915.
8. IJsselmuiden AJ, Serruys PW, Scholte A, Kiemeneij F, Slagboom T, vd Wieken LR, Tangelder GJ, Laarman GJ. Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: Six month results of a randomized trial. Eur Heart J. 2003;24:421-429.
9. Brueck M, Scheinert D, Wortmann A, Bremer J, von Korn H, Klinghammer L, Kramer W, Flachskampf FA, Daniel WG, Ludwig J. Direct coronary stenting versus predilatation followed by stent placement. Am J Cardiol. 2002;90:1187-1192.
10. Martinez-Elbal L, Ruiz-Nodar JM, Zueco J, Lopez-Minguez JR, Moreu J, Calvo I, Ramirez JA, Alonso M, Vazquez N, Lezaun R, Rodriguez C. Direct coronary stenting versus stenting with balloon pre-dilation: Immediate and follow-up results of a multicentre, prospective, randomized study. The disco trial. Direct stenting of coronary arteries. Eur Heart J. 2002;23:633-640.
11. Burzotta F, Trani C, Prati F, Hamon M, Mazzari MA, Mongiardo R, Sabatier R, Boccanelli A, Schiavoni G, Crea F. Comparison of outcomes (early and six- month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials). Am J Cardiol. 2003;91:790-796.
12. Baim DS, Flatley M, Caputo R, O'Shaughnessy C, Low R, Fanelli C, Popma J, Fitzgerald P, Kuntz R. Comparison of pre-dilatation vs. direct stenting in coronary treatment using the medtronic ave s670 coronary stent system (the PREDICT trial). Am J Cardiol. 2001;88:1364-1369.
13. Dawkins KD, Chevalier B, Suttorp MJ, Thuesen L, Benit E, Bethencourt A, Morjaria U, Veldhof S, Dorange C, van Weert A. Effectiveness of "direct" stenting without balloon predilatation (from the multilink tetra randomised european direct stent study [trends]). Am J Cardiol. 2006;97:316-321.
14. Carrie D, Khalife K, Citron B, Izaaz K, Hamon M, Juiliard JM, Leclercq F, Fourcade J, Lipiecki J, Sabatier R, Boulet V, Rinaldi JP, Mourali S, Fatouch M, El Mokhtar E, Aboujaoude G, Elbaz M, Grolleau R, Steg PG, Puel J. Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. BET (Benefit Evaluation of Direct Coronary Stenting) Study Group. Am J Cardiol. 2001;87:693-698.
15. Lam JY, Chesebro JH, Steele PM, Dewanjee MK, Badimon L, Fuster V. Deep arterial injury during experimental angioplasty: Relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol. 1986;8:1380-1386.
16. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol. 1992;19:267-274.
17. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31:224-230.
18. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005;112:270-278.
19. McCullough P. Outcomes of contrast-induced nephropathy: Experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv. 2006;67:335-343.
20. Naidu SS, Selzer F, Jacobs A, Faxon D, Marks DS, Johnston J, Detre K, Wilensky RL. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol. 2003;92:1160-1164.
21. Cohen HA, Williams DO, Holmes DR, Jr., Selzer F, Kip KE, Johnston JM, Holubkov R, Kelsey SF, Detre KM. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: A report from the NHLBI Dynamic Registry. Am Heart J. 2003;146:513-519.
22. Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC, Minutello RM. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) New York State Angioplasty Registry. Am J Cardiol. 2006;98:1334-1339.
23. Wu C, Hannan EL, Walford G, Ambrose JA, Holmes DR, Jr., King SB, 3rd, Clark LT, Katz S, Sharma S, Jones RH. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006;47:654-660.
24. Shaw RE, Anderson HV, Brindis RG, Krone RJ, Klein LW, McKay CR, Block PC, Shaw LJ, Hewitt K, Weintraub WS. Development of a risk adjustment mortality model using the american college of cardiology-national cardiovascular data registry (acc-ncdr) experience: 1998-2000. J Am Coll Cardiol. 2002;39:1104-1112.